Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2473 of 6351
-
New drug could protect children with cancer from chemo side effects
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma and treated with myelosuppressive chemotherapy.
Phase 2 • Sponsor: Spectrum Pharmaceuticals, Inc • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can adjusting body weight reveal hidden gait impairments in cerebral palsy?
Knowledge-focused OngoingThe purpose of this study is to investigate lower limb impairments in children with bilateral cerebral palsy during stepping tasks.
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New pill aims to calm schizophrenia symptoms fast
Symptom relief CompletedThe purpose of this study is to determine the efficacy, safety, tolerability and pharmacokinetics (PK) properties of CPL500036 compound (PDE10a inhibitor) in patients with an acute exacerbation of schizophrenia after 28 days of administration..
Phase 2 • Sponsor: Celon Pharma SA • Aim: Symptom relief
Last updated Jun 26, 2026 16:11 UTC
-
Wearable tech and home visits aim to ease the burden on dementia caregivers
Symptom relief CompletedThe proposed study will test a 3-month, community health worker (CHW) delivered home visit, culturally and language-appropriate intervention for ethnic and underserved dementia family caregivers of persons with dementia (PWD) using wearable technology for real time monitoring of …
Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Brain oxygen watch during heart surgery may shield memory
Knowledge-focused CompletedNeurological dysfunction continues to be one of the complications of considerable concern in patients undergoing cardiac surgery. It was previously reported in the literature, that cerebral oxygen desaturation during cardiac surgery was associated with an increased incidence of c…
Sponsor: Instituto Nacional de Cardiologia de Laranjeiras • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Brain training may delay dementia in At-Risk seniors
Disease control OngoingBackground: Dementia is a debilitating and devastating disease impacting the individuals, their families, and the health care system. According to the World Health Organization the dementia epidemic could overwhelm the global health care system and undermine social and economic …
Sponsor: Sorlandet Hospital HF • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
ALS study aims to uncover hidden nerve damage clues
Knowledge-focused Recruiting nowThe goal of this interventional non-pharmacological study is to evaluate, using a multimodal approach, the progression of autonomic and sensory involvement in in amyotrophic lateral sclerosis (ALS) patients enrolled within 18 months from motor onset and its relationship with the …
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Chocolate and pills: could they keep seniors on their feet?
Disease control OngoingThe COcoa Supplement and Multivitamin Outcomes Study (COSMOS; NCT02422745) is a randomized clinical trial of cocoa extract supplement (containing a total of 500 mg/d flavanols, including 80 mg. (-)-epicatechins), and a standard multivitamin supplement to reduce the risk of cardio…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for nail psoriasis: tildrakizumab shows promise in trial
Symptom relief CompletedPhase 3b study to Assess the Efficacy and Safety of Tildrakizumab in the Treatment of Moderate to Severe Nail Psoriasis
Phase 3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Brain & hormones: why women face rising alcohol risks
Knowledge-focused Recruiting nowThe sex gap in alcohol consumption is closing rapidly, due to alarming increases among women. From 2002-2013, Alcohol Use Disorder (AUD) increased 84% for women, compared to 35% for men. As such, there is an urgent need to determine the factors underlying sex differences in risk …
Sponsor: Jessica Weafer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Tiny particles in blood may reveal how well breast cancer chemo works
Diagnosis Recruiting nowExtracellular vesicles (EVs) are lipid bilayer-delimited particles, naturally released from the cells and mediators of intercellular cross-talk. In breast cancer (BC), EVs seem to be involved in the tumor microenvironment's shaping, in cancer cells invasion and in the set-up of m…
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
20,000 cancer patients to get genetic profiling in hunt for new treatments
Knowledge-focused Recruiting nowThe objective of STING study is to perform high throughput molecular analysis (next generation sequencing +/- immunological profiling) to estimate the proportion of patients with cancer presenting at least one targetable genomic alteration.
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
COVID-19 drug trial halted early: what happened with ensovibep?
Disease control Stopped earlyThe purpose of this study is to establish the antiviral efficacy of ensovibep against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in humans, identify the optimal dose, and demonstrate its clinical value for treating COVID-19 in adult ambulatory patients.
Phase 2/3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a common mushroom help fight prostate cancer?
Disease control PausedThis phase II trial studies how well white button mushroom supplement works in reducing prostate-specific antigen (PSA) levels in patients with prostate cancer that has come back (recurrent) or has favorable risk and has not undergone any therapy (therapy naive). PSA is a blood m…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
A digital tool may help doctors and patients pick the best heart prevention strategy together
Disease control CompletedCardiovascular (CV) disease is the #1 cause of premature mortality and substantial morbidity in the U.S. Despite clinical guidelines, most clinical interventions are implemented in people at relatively lower CV risk, and few among people at the highest risk. Shared decision makin…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New program aims to boost HIV testing and care for teen girls in zambia
Prevention CompletedThe study team will test a multilevel package of interventions to connect adolescent girls and young women (AGYW) with a source of regular care to provide a sustainable platform for successful implementation of regular human immunodeficiency virus (HIV) testing and support for li…
Sponsor: RTI International • Aim: Prevention
Last updated Jun 26, 2026 17:18 UTC
-
Could a simple ultrasound replace CT scans for kids with belly injuries?
Diagnosis CompletedThis multicenter study aims to evaluate the accuracy of contrast-enhanced ultrasound (CEUS) in diagnosing abdominal solid organ injuries in pediatric patients. Up to 130 subjects will complete the study across approximately 5-10 sites in the US, with up to 30 patients in the trai…
Phase 1/2 • Sponsor: David Mooney • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Timing is everything: new study tests best time to start diabetes meds in pregnancy
Disease control OngoingThe goal of this study is to compare two different thresholds for initiation of medical treatment for GDM. Pregnant women diagnosed with GDM will be randomized to either start pharmacotherapy when they have reached at least 20% or at least 40% of capillary blood glucose (CBG) val…
Phase 4 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Heart attack patients may ditch daily pills, major trial investigates
Disease control Recruiting nowThe aim of the study is to determine whether discontinuation of β-blocker after at least 1 year of β-blocker therapy is noninferior to continuation of β-blocker in patients without heart failure (HF) or left ventricular systolic dysfunction after acute myocardial infarction (AMI)…
Phase 4 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Smart ventilator adjusts breath support automatically for COPD patients
Disease control CompletedPatients with chronic obstructive pulmonary disease (COPD) can eventually progress to respiratory failure, where they cannot adequately exchange oxygen and carbon dioxide, leading to worsening breathlessness, frequent hospitalisations and death. Non-invasive ventilation (NIV) is …
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC